StockTake: AdAlta subsidiary AdCella secures funding boost

AdAlta’s subsidiary AdCella receives an investment from SYNthesis BioVentures – here’s what this means for both companies.

AdAlta (ASX:1AD) has built on a deal with SYNthesis BioVentures Fund One, which plans to invest $500,000 in seed funding for its subsidiary AdCella, with a total commitment of up to $2 million.

It means AdCella now won’t rely on further capital from AdAlta and it will also secure AdCella’s initial asset portfolio.

Watch the video for the latest.

This video was developed in collaboration with AdAlta, a Stockhead advertiser at the time of publishing.

This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

Originally published as StockTake: AdAlta subsidiary AdCella secures funding boost